125 related articles for article (PubMed ID: 7962296)
1. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.
Späth-Schwalbe E; Born J; Schrezenmeier H; Bornstein SR; Stromeyer P; Drechsler S; Fehm HL; Porzsolt F
J Clin Endocrinol Metab; 1994 Oct; 79(4):1212-4. PubMed ID: 7962296
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.
Mastorakos G; Weber JS; Magiakou MA; Gunn H; Chrousos GP
J Clin Endocrinol Metab; 1994 Oct; 79(4):934-9. PubMed ID: 7962300
[TBL] [Abstract][Full Text] [Related]
3. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos G; Chrousos GP; Weber JS
J Clin Endocrinol Metab; 1993 Dec; 77(6):1690-4. PubMed ID: 8263159
[TBL] [Abstract][Full Text] [Related]
4. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
[TBL] [Abstract][Full Text] [Related]
5. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
6. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
Crofford LJ; Kalogeras KT; Mastorakos G; Magiakou MA; Wells J; Kanik KS; Gold PW; Chrousos GP; Wilder RL
J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
[TBL] [Abstract][Full Text] [Related]
7. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
8. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women.
Puder JJ; Freda PU; Goland RS; Wardlaw SL
J Clin Endocrinol Metab; 2001 Jun; 86(6):2403-8. PubMed ID: 11397831
[TBL] [Abstract][Full Text] [Related]
9. Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate.
Xiao E; Xia-Zhang L; Vulliémoz NR; Ferin M; Wardlaw SL
Endocrinology; 2003 May; 144(5):1736-41. PubMed ID: 12697678
[TBL] [Abstract][Full Text] [Related]
10. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
11. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
Buckley TM; Mullen BC; Schatzberg AF
Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
[TBL] [Abstract][Full Text] [Related]
12. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
Wilson ME; Fisher J; Brown J
Physiol Behav; 2005 Mar; 84(3):449-58. PubMed ID: 15763583
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
Giordano R; Bo M; Pellegrino M; Vezzari M; Baldi M; Picu A; Balbo M; Bonelli L; Migliaretti G; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2.
Hanisch UK; Rowe W; Sharma S; Meaney MJ; Quirion R
Endocrinology; 1994 Dec; 135(6):2465-72. PubMed ID: 7988433
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.
Beishuizen A; Thijs LG
J Endotoxin Res; 2003; 9(1):3-24. PubMed ID: 12691614
[TBL] [Abstract][Full Text] [Related]
16. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
Kok P; Kok SW; Buijs MM; Westenberg JJ; Roelfsema F; Frölich M; Stokkel MP; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154
[TBL] [Abstract][Full Text] [Related]
17. Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis.
Mastorakos G; Ilias I
Z Rheumatol; 2000; 59 Suppl 2():II/75-9. PubMed ID: 11155809
[TBL] [Abstract][Full Text] [Related]
18. Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
Streeten DH; Anderson GH; Dalakos TG; Seeley D; Mallov JS; Eusebio R; Sunderlin FS; Badawy SZ; King RB
Endocr Rev; 1984; 5(3):371-94. PubMed ID: 6088218
[TBL] [Abstract][Full Text] [Related]
19. Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.
Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K
Psychoneuroendocrinology; 2010 Nov; 35(10):1438-45. PubMed ID: 20554120
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia.
Geiss A; Rohleder N; Anton F
Psychoneuroendocrinology; 2012 May; 37(5):671-84. PubMed ID: 22000300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
